Goodwin Guides BridgeBio Oncology Therapeutics in Debut as a Publicly Traded Company
August 14, 2025
August 14, 2025
BOSTON, Massachusetts, Aug. 14 [Category: BizLaw/Legal] -- Goodwin, a law firm, issued the following news release:
* * *
Goodwin Guides BridgeBio Oncology Therapeutics in Debut as a Publicly Traded Company
*
The Life Sciences and Special Purpose Acquisition Companies teams guided BridgeBio Oncology Therapeutics, Inc. ("BBOT") on the closing of its previously announced business combination with Helix Acquisition Corp. II, a special pur . . .
* * *
Goodwin Guides BridgeBio Oncology Therapeutics in Debut as a Publicly Traded Company
*
The Life Sciences and Special Purpose Acquisition Companies teams guided BridgeBio Oncology Therapeutics, Inc. ("BBOT") on the closing of its previously announced business combination with Helix Acquisition Corp. II, a special pur . . .